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The neuromuscular disease Spinal bulbar muscular atrophy (SBMA) associates with loss of bulbar or 
spinal motoneurons and skeletal muscle atrophy. SBMA is caused by a mutation of the androgen 
receptor (AR) gene resulting in a protein with an elongated polyglutamine (polyQ) tract. ARpolyQ 
acquires nuclear toxicity after binding testosterone, which induces AR nuclear translocation and 
ARpolyQ misfolding. Misfolded ARpolyQ is prone to aggregate, a process counteracted by the protein 
quality control (PQC) system. This system comprises chaperones and the degradative pathways 
(proteasome and autophagy). Several data suggest that misfolded ARpolyQ is mainly process via 
autophagy, and causes autophagy flux blockage. Restoration of a functional autophagy is beneficial to 
cells expressing misfolded ARpolyQ. A peculiar form of autophagy is the "chaperone-assisted 
selective autoghagy" (CASA), which relies on dynein-mediated retrograde transport of the CASA 
(HSPB8-BAG3-HSC70-CHIP) complex. This complex binds misfolded ARpolyQ enhancing its 
clearance. In immortalized motoneurons (MNs) and MNs derived from SBMA iPSCs we found that 
inhibition of dynein-mediated retrograde transport reduces ARpolyQ accumulation enhancing its 
clearance. This process is mediated by the HSC70 co-chaperone BAG1 which activate a 
compensatory mechanism alternative to HSPB8/BAG3. In the knock-in ARQ113 SBMA mouse model 
(KIARQ113), we found that in affected muscle both BAG1 and BAG3 are upregulated, with an 
increased BAG3:BAG1 ratio which preferentially routes misfolded ARpolyQ to autophagy.   
On these basis and on our previous in vitro studies, we tested bicalutamide (an antiandrogen which 
prevent AR nuclear translocation) and trehalose (an autophagy activator) in KIARQ113 mouse. We 
found found that mice survival was not significantly modified by the treatments, but an apparent 
positive trend was present. In Rotarod test KIARQ113 mice the impaired motor coordination was 
completely recovered by trehalose treatment. Bicalutamide administered at early stages worsened this 
phenotype (probably because of its anti-anabolic effects on muscle development), but recovered the 
motor coordination phenotype when administered at later stages (when muscle reached the adulthood 
stage). Grip strength test in KI mice showed  decreased forelimb muscle force, which was further 
decreased by early, but not late bicalutamide treatment. Hystopathological analyses of mouse 
gastrocnemius reveal no variation associated to treatments in Feret min and max diameter of the KI 
mouse muscle fibers. Molecular analyses of gastrocnemius muscle of treated mice showed an 
increased PGC1alpha expression, paralleled by an increased mitochondrial DNA content and 
enhanced mitochondrial complex levels (particularly of complex V - ATP synthase subunits and 
complex III). Thus, the combined trehalose/bicalutamide treatment ameliorates muscle energy 
production and counteracts ARpolyQ mediated toxicity in vivo. 
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